Table:
begin	end	state
1	27	cytoplasmic
28	46	transmembrane
47	65	non-cytoplasmic
66	85	transmembrane
86	96	cytoplasmic
97	117	transmembrane
118	122	non-cytoplasmic
123	147	transmembrane
148	157	cytoplasmic
158	179	transmembrane
180	190	non-cytoplasmic
191	213	transmembrane
214	255	cytoplasmic
256	277	transmembrane
278	288	non-cytoplasmic
289	310	transmembrane
311	321	cytoplasmic
322	341	transmembrane
342	346	non-cytoplasmic
347	367	transmembrane
368	373	cytoplasmic
374	397	transmembrane
398	413	non-cytoplasmic
414	434	transmembrane
435	439	cytoplasmic

Input:
>H281DRAFT_00211
MASPANPLHHPGAGAPPSTFEEATYRKVNWRLAPLLMLCYVVAYLDRVNVGFAKLQMTSD
LGLSDAVYGFGAGIFFVGYFFFEIPSNVILHKVGARVWIARIMVSWGVISMLTMFVTTPT
MFYVMRFLLGVAEAGFFPGIILYLTYWYPSHRRGRMTTWFMTAIALSGVIGGPVSGYILK
TFNGMNGWHGWQWLFLLEGIPSVLVGILVFVALDDRISKAKWLTKEEKELLERHVSAEEA
TKHDMPIRQVLTSGRVLMLSFTYFSFVMGLYGVSFWLPTIIKATGVTDAFAIGLLSAVPF
AAAVVAMVFVARSADRTRERRWHIALPAFAGAIGLVLSVVWAQNTLLAMASLTLATMGIL
TTLPLFWSLPTAILAGTGAAAGIAMINSIGNLAGFLSPYAVGWLKQATAANDSGMYMLAA
FMVVGGLLAISVPAKMVNR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server